Ranjit Bindra

Company: Modifi Bio

Job title: Co-Founder

Seminars:

Exploiting DNA Repair Defects via Direct DNA Modification – A New Paradigm in Oncology Drug Development 3:45 pm

Overview of DNA modifiers (DMs) and how they can be engineered to exploit DDR defects Strategies to evade known drug resistance pathways using DMs Potential for combination therapies with DMsRead more

day: Day One